Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,600 | 2,516 | 2,872 | 5,633 | 10,807 |
| Income taxes - deferred | N/A | N/A | -6 | 113 | -4,873 |
| Accounts receivable | -1,563 | 6,420 | 3,618 | 16,983 | -6,699 |
| Other Working Capital | 1,652 | 3,450 | 6,245 | 21,828 | 17,063 |
| Other Operating Activity | -7,550 | -24,725 | -28,798 | -57,770 | -54,071 |
| Operating Cash Flow | $-4,861 | $-12,339 | $-16,069 | $-13,213 | $-37,773 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 347 | 178 | 7 | 311 | 59 |
| Net Acquisitions | 0 | 5,262 | 6,014 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -2 |
| Other Investing Activity | 66 | 1,432 | -863 | -276 | -7,503 |
| Investing Cash Flow | $413 | $6,872 | $5,158 | $35 | $-7,446 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,915 | -696 | N/A | N/A | N/A |
| Debt Issued | 799 | N/A | 1,341 | 0 | 36,138 |
| Debt Repayment | -136 | -248 | -948 | -2,962 | -14,061 |
| Common Stock Issued | N/A | N/A | 0 | 30,917 | N/A |
| Other Financing Activity | 405 | 576 | 403 | -151 | 4,345 |
| Financing Cash Flow | $-1,847 | $-368 | $796 | $27,804 | $26,422 |
| Exchange Rate Effect | 4 | -329 | 150 | -429 | 83 |
| Beginning Cash Position | 17,981 | 24,145 | 34,110 | 19,913 | 38,627 |
| End Cash Position | 11,690 | 17,981 | 24,145 | 34,110 | 19,913 |
| Net Cash Flow | $-6,295 | $-5,835 | $-10,115 | $14,626 | $-18,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,861 | -12,339 | -16,069 | -13,213 | -37,773 |
| Capital Expenditure | -154 | -471 | -863 | -783 | -7,503 |
| Free Cash Flow | -5,015 | -12,810 | -16,932 | -13,996 | -45,276 |